The dual roles of cellular senescence in lung cancer—acting as a tumor-suppressive mechanism via p53/p21/p16-mediated cell cycle arrest while driving malignancy through SASP-mediated inflammation—underscore its context-dependent impact on disease progression (139). Here, CDKN2A is linked to lung cancer.